Understanding Non-Adherence in a Botswana Clinical Trial
Author Information
Author(s): Gust Deborah A., Mosimaneotsile Barudi, Mathebula Unami, Chingapane Balladiah, Gaul Zaneta, Pals Sherri L., Samandari Taraz, Tyagi Anil Kumar
Primary Institution: Centers for Disease Control and Prevention (CDC)
Hypothesis
What factors contribute to non-adherence and loss to follow-up in a clinical trial among HIV-infected adults in Botswana?
Conclusion
Men had higher odds of non-adherence and loss to follow-up than women.
Supporting Evidence
- Men had higher odds of being non-adherent and lost to follow-up.
- Non-adherent participants reported difficulties with the regimen.
- Younger age was associated with non-adherence.
- Competing commitments and side effects were common reasons for stopping medication.
Takeaway
In a study about HIV treatment in Botswana, it was found that men were more likely to stop taking their medicine or miss appointments than women.
Methodology
The study involved a 3-year clinical trial with 1995 participants, using surveys and logistic regression to analyze factors associated with non-adherence and loss to follow-up.
Potential Biases
Self-reported responses may lead to reporting bias.
Limitations
The study was cross-sectional, self-reported data may introduce bias, and not all relevant variables may have been captured.
Participant Demographics
Participants were HIV-infected adults, with a higher proportion of men and a mean age of 37 years.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95%CI 1.24–4.04 for non-adherence; 95%CI 1.50–6.33 for loss to follow-up
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website